HomeLonza to buy back $2.17 billion worth of shares, backs mid-term growthFILE PHOTO: Logo of Swiss contract drug maker Lonza is

FILE PHOTO: Logo of Swiss contract drug maker Lonza is

FILE PHOTO: The logo of Swiss contract drug maker Lonza is seen at its headquarters in Basel, Switzerland October 1, 2020. REUTERS/Arnd Wiegmann/File Photo

How Trump’s Pentagon pick Hegseth fell out of love with the U.S. military

November 15, 2024

Palantir shares rally to fresh record on plans for move to Nasdaq

November 15, 2024

EV companies, battery makers urge Trump not to kill vehicle tax credits

November 15, 2024

Musk expands lawsuit against OpenAI, adding Microsoft and antitrust claims

November 15, 2024

FILE PHOTO: Logo of Swiss contract drug maker Lonza is

Most Read

How Trump’s Pentagon pick Hegseth fell out of love with the U.S. military

Palantir shares rally to fresh record on plans for move to Nasdaq

EV companies, battery makers urge Trump not to kill vehicle tax credits

Musk expands lawsuit against OpenAI, adding Microsoft and antitrust claims

EDITOR PICKS

How Trump’s Pentagon pick Hegseth fell out of love with the U.S. military

Palantir shares rally to fresh record on plans for move to Nasdaq

EV companies, battery makers urge Trump not to kill vehicle tax credits

POPULAR POSTS

How Trump’s Pentagon pick Hegseth fell out of love with the U.S. military

Palantir shares rally to fresh record on plans for move to Nasdaq

EV companies, battery makers urge Trump not to kill vehicle tax credits

POPULAR CATEGORY